SCHEMBL14346059

SCHEMBL14346059

CC(C)(C)c1ccc2cc3c(N)n[nH]c3cc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MITF O75030 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ JAK2 O60674 9/20 0.42
▸ PDPK1 O15530 13/20 0.40
▸ AURKA O14965 5/20 0.40
▸ AURKB Q96GD4 5/20 0.40
▸ TGFBR1 P36897 5/20 0.40
▸ ROCK1 Q13464 4/20 0.40
▸ JAK3 P52333 3/20 0.39
▸ CHUK O15111 2/20 0.39
▸ RPS6KB1 P23443 2/20 0.39
▸ CDK2 P24941 2/20 0.39
▸ KDR P35968 2/20 0.39
▸ SYK P43405 2/20 0.39
▸ PLK4 O00444 1/20 0.39
▸ CHEK1 O14757 1/20 0.39
▸ ROCK2 O75116 1/20 0.39
▸ MAP4K4 O95819 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14346062 0.83 LRRK2 (0.47) MITFALDH1A1TP53KMT2AJAK2
SCHEMBL1690470 0.82 JAK2 (0.55) MITFALDH1A1TP53KMT2AJAK2
SCHEMBL84515 0.82 PDPK1 (0.55) MITFALDH1A1TP53KMT2AJAK2
SCHEMBL15601766 0.79 PDPK1 (0.47) ALDH1A1JAK2PDPK1AURKAAURKB
SCHEMBL6479720 0.76 JAK2 (0.66) MITFALDH1A1TP53KMT2AJAK2
SCHEMBL12907189 0.76 JAK2 (0.66) MITFALDH1A1TP53KMT2AJAK2
SCHEMBL12125261 0.75 MEN1 (0.50) ALDH1A1KMT2AJAK2PDPK1AURKA
SCHEMBL19286495 0.74 KIF11 (0.38) MITFALDH1A1TP53KMT2A
SCHEMBL29968032 0.73 JAK2 (0.65) JAK2PDPK1AURKBROCK1JAK3
SCHEMBL28871206 0.73 JAK2 (0.65) JAK2PDPK1AURKBROCK1JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293499-A1 Intracellular Kinase Inhibitors MANNKIND CORPORATION (US) 2007-12-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293499-A1 Intracellular Kinase Inhibitors PI4KB, BTK, LTK MITF 3220/4885ALDH1A1 4370/4885TP53 605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback